IlluminOss Medical Announces the Enrollment of First Patient in Proximal Humerus Fracture Repair Trial at Albert Schweitzer Hospital (press release)
Light Fix Proximal Humerus Trial Led by Dr. Paul Vegt to Apply IlluminOss' Patient-Conforming Implant Technology to Fragility Fractures; First Use of New Latitude Radiopaque Markings
IlluminOss Medical, a commercial stage medical device company focused on minimally invasive orthopedic fracture repair, today announced that the first patient has been enrolled at Albert Schweitzer Hospital in the Netherlands as part of its EU Light Fix Proximal Humerus Fracture Repair Trial for the treatment of osteoporotic and fragility fractures. The trial at Albert Schweitzer Hospital is being led by Dr. Paul Vegt, M.D., Ph.D., and is an expansion of IlluminOss' technology into the treatment of osteoporotic and fragility fractures most common in the elderly.
IlluminOss Medical designs, develops and markets orthopedic fracture repair products that leverage its proprietary bone stabilization technology, the IlluminOss System. This minimally invasive technology allows for fracture fixation through revolutionary patient-specific intramedullary implants. T...
